The Bombay High Court has told the Tukaram Mundhe-led Maharashtra FDA to use its powers judiciously after Cadila Pharmaceuticals challenged a ban on the sale of some medicines. The court questioned the regulators approach and accepted its assurance to revoke the orders, issue show-cause notices and hear the company before taking further action.

The Bombay High Court criticized the Maharashtra FDA for its drastic actions against companies. The court directed the regulator to grant hearings before taking severe measures.…

Bombay HC urges FDA to exercise restraint, ensuring pharmaceutical companies receive fair hearings before regulatory actions.